Responses
Immune cell therapies and immune cell engineering
Original research
IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM
Compose a Response to This Article
Other responses
No responses have been published for this article.
